 Evidence malignant features mature teratoma total specimens patients residual stable teratoma mature teratoma chemotherapy clinicopathological deoxyribonucleic acid DNA cytometric variables presence proliferative antigen tumor marker levels attempt clinical behavior flow cytometric histological data stable teratomas nonseminomatous germ tumors chemotherapy DNA content residual teratoma primary testicular tumors Histological analysis stable teratomas significant difference proliferative cellular nuclear antigen epithelial component teratoma alpha-Fetoprotein beta-human chorionic gonadotropin carcinoembryonic antigen fluid excised teratomas concomitant serum levels normal aneuploidy cystic fluid tumor markers malignant phenotype post-chemotherapy residual teratomas Therefore complete surgical removal essential benign histological appearance